In addition, TGF-β induces endothelial-to-mesenchymal transition in tumor endothelial cells, resulting in the downregulation of adhesion molecules such as vascular endothelial (VE)-cadherin and weakened endothelial barrier function (Ma et al., 2020). This evidence concerns the gene TGFB1 and neoplasm.